Environmental factors involved in carcinogenesis of urothelial cell carcinomas of the upper urinary tract

BJU International

Volumn 104, Issue 10, 2009, Pages 1436-1440

  Colin, Pierre ^a   Koenig, Philippe ^a   Ouzzane, Adil ^a   Berthon, Nicolas ^a   Villers, Arnauld ^a   Biserte, Jacques ^a   Rouprêt, Morgan ^b  

^a LILLE UNIVERSITY HOSPITAL   (France)

^b PITIÉ SALPÊTRIÈRE HOSPITAL   (France)

Author keywords

Aristolochic acid; Balkan endemic nephropathy; Blackfoot disease; Bladder cancer; Occupational exposure; Renal pelvis; Ureter; Urinary tract cancer; Urothelial carcinoma

Indexed keywords

ARISTOLOCHIC ACID; ARSENIC; CYCLOPHOSPHAMIDE; IFOSFAMIDE; LAXATIVE; MUTAGENIC AGENT; PARACETAMOL; PHENACETIN; POLYCYCLIC AROMATIC HYDROCARBON; SULFOTRANSFERASE;

BLACKFOOT DISEASE; CANCER GROWTH; CANCER RISK; CANCER SUSCEPTIBILITY; CARCINOGENESIS; CATALYSIS; CHINESE HERB; COFFEE; DETOXIFICATION; DISEASE ASSOCIATION; DRUG ABUSE; ENVIRONMENTAL FACTOR; GENETIC POLYMORPHISM; GYNECOLOGIC CANCER; HUMAN; HYPERTENSION; ILEX PARAGUARIENSIS; INCIDENCE; INTERSTITIAL NEPHRITIS; KIDNEY DISEASE; MULTIFACTORIAL INHERITANCE; NONHUMAN; OCCUPATIONAL EXPOSURE; PATHOPHYSIOLOGY; PRIORITY JOURNAL; RADIOTHERAPY; SHORT SURVEY; SMOKING; STONE FORMATION; TAIWAN; TEA; TOBACCO; URINARY TRACT CARCINOMA; URINARY TRACT INFECTION;

ENVIRONMENTAL EXPOSURE; FEMALE; HUMANS; KIDNEY NEOPLASMS; KIDNEY PELVIS; MALE; RISK FACTORS; URETERAL NEOPLASMS;

EID: 72349086941     PISSN: 14644096     EISSN: 1464410X     Source Type: Journal    
DOI: 10.1111/j.1464-410X.2009.08838.x     Document Type: Short Survey

References (31)

1. Mazeman E. [Tumors of the upper excretory urinary tract, calices, renal pelvis and ureter]. J Urol Nephrol (Paris) 1972 78 (Suppl. 9 1 219
2. Hall MC, Womack S, Sagalowsky AI, Carmody T, Erickstad MD, Roehrborn CG. Prognostic factors, recurrence, and survival in transitional cell carcinoma of the upper urinary tract: a 30-year experience in 252 patients. Urology 1998 52 : 594 601
3. Kirkali Z, Chan T, Manoharan M et al. Bladder cancer: epidemiology, staging and grading, and diagnosis. Urology 2005 66 (Suppl. 1 4 34
4. Munoz JJ, Ellison LM. Upper tract urothelial neoplasms: incidence and survival during the last 2 decades. J Urol 2000 164 : 1523 1525
5. Fernandez MI, Shariat SF, Margulis V et al. Evidence-based sex-related outcomes after radical nephroureterectomy for upper tract urothelial carcinoma: results of large multicenter study. Urology 2009 73 : 142 146
6. Catto JW, Yates DR, Rehman I et al. Behavior of urothelial carcinoma with respect to anatomical location. J Urol 2007 177 : 1715 1720
7. Roupret M, Cancel-Tassin G, Comperat E et al. Phenol sulfotransferase SULT1A1*2 allele and enhanced risk of upper urinary tract urothelial cell carcinoma. Cancer Epidemiol Biomarkers Prev 2007 16 : 2500 2503
8. Hung RJ, Boffetta P, Brennan P et al. GST, NAT, SULT1A1, CYP1B1 genetic polymorphisms, interactions with environmental exposures and bladder cancer risk in a high-risk population. Int J Cancer 2004 110 : 598 604 (Pubitemid 38658026)
9. Pommer W, Bronder E, Klimpel A, Helmert U, Greiser E, Molzahn M. Urothelial cancer at different tumour sites: role of smoking and habitual intake of analgesics and laxatives. Results of the Berlin Urothelial Cancer Study. Nephrol Dial Transplant 1999 14 : 2892 2897
10. McLaughlin JK, Silverman DT, Hsing AW et al. Cigarette smoking and cancers of the renal pelvis and ureter. Cancer Res 1992 52 : 254 257
11. Shinka T, Miyai M, Sawada Y, Inagaki T, Okawa T. Factors affecting the occurrence of urothelial tumors in dye workers exposed to aromatic amines. Int J Urol 1995 2 : 243 248
12. Clavel J, Mandereau L, Limasset JC, Hemon D, Cordier S. Occupational exposure to polycyclic aromatic hydrocarbons and the risk of bladder cancer: a French case-control study. Int J Epidemiol 1994 23 : 1145 1153
13. Pesch B, Haerting J, Ranft U, Klimpel A, Oelschlagel B, Schill W. Occupational risk factors for urothelial carcinoma: agent-specific results from a case-control study in Germany. MURC Study Group. Multicenter Urothelial and Renal Cancer. Int J Epidemiol 2000 29 : 238 247
14. Holmang S, Johansson SL. Synchronous bilateral ureteral and renal pelvic carcinomas: incidence, etiology, treatment and outcome. Cancer 2004 101 : 741 747
15. Stewart JH, Hobbs JB, McCredie MR. Morphologic evidence that analgesic-induced kidney pathology contributes to the progression of tumors of the renal pelvis. Cancer 1999 86 : 1576 1582
16. Markovic N, Ignjatovic I, Cukuranovic R, Petrovic B, Kocic B, Stefanovic V. Decreasing incidence of urothelial cancer in a Balkan endemic nephropathy region in Serbia. A surgery based study from 1969 to 1998. Pathol Biol (Paris) 2005 53 : 26 9
17. Debelle FD, Vanherweghem JL, Nortier JL. Aristolochic acid nephropathy: a worldwide problem. Kidney Int 2008 74 : 158 169
18. Dragicevic D, Djokic M, Pekmezovic T et al. Survival of patients with transitional cell carcinoma of the ureter and renal pelvis in Balkan endemic nephropathy and non-endemic areas of Serbia. BJU Int 2007 99 : 1357 1362
19. Grollman AP, Shibutani S, Moriya M et al. Aristolochic acid and the etiology of endemic (Balkan) nephropathy. Proc Natl Acad Sci USA 2007 104 : 12129 12134
20. Arlt VM, Stiborova M, vom Brocke J et al. Aristolochic acid mutagenesis: molecular clues to the aetiology of Balkan endemic nephropathy-associated urothelial cancer. Carcinogenesis 2007 28 : 2253 2261
21. Laing C, Hamour S, Sheaff M, Miller R, Woolfson R. Chinese herbal uropathy and nephropathy. Lancet 2006 368 : 338
22. Lord GM, Cook T, Arlt VM, Schmeiser HH, Williams G, Pusey CD. Urothelial malignant disease and Chinese herbal nephropathy. Lancet 2001 358 : 1515 1516
23. Stiborova M, Frei E, Schmeiser HH. Biotransformation enzymes in development of renal injury and urothelial cancer caused by aristolochic acid. Kidney Int 2008 73 : 1209 1211
24. Tan LB, Chen KT, Guo HR. Clinical and epidemiological features of patients with genitourinary tract tumour in a blackfoot disease endemic area of Taiwan. BJU Int 2008 102 : 48 54
25. Yang MH, Chen KK, Yen CC et al. Unusually high incidence of upper urinary tract urothelial carcinoma in Taiwan. Urology 2002 59 : 681 687
26. Lamm SH, Engel A, Penn CA, Chen R, Feinleib M. Arsenic cancer risk confounder in southwest Taiwan data set. Environ Health Perspect 2006 114 : 1077 1082
27. Chow WH, Lindblad P, Gridley G et al. Risk of urinary tract cancers following kidney or ureter stones. J Natl Cancer Inst 1997 89 : 1453 1457
28. Liaw KL, Linet MS, McLaughlin JK et al. Possible relation between hypertension and cancers of the renal pelvis and ureter. Int J Cancer 1997 70 : 265 268
29. McDougal WS, Cramer SF, Miller R. Invasive carcinoma of the renal pelvis following cyclophosphamide therapy for nonmalignant disease. Cancer 1981 48 : 691 695
30. Saito M, Kondo A, Kato T, Kobayashi M, Miyake K. Radiation-induced urothelial carcinoma. Urol Int 1996 56 : 254 255
31. De Stefani E, Boffetta P, Deneo-Pellegrini H et al. Non-alcoholic beverages and risk of bladder cancer in Uruguay. BMC Cancer 2007 7 : 57